Limit Antibiotics Use To Single Dose To Prevent Infection At Surgical Site: NCDC

NEW DELHI: It is a common practice to put patients undergoing surgery on antibiotics to prevent infections. But what should be the duration of such medication?

According to the National Centre for Disease Control (NCDC), use of antibiotics to prevent infections at the surgical site should be limited to a single dose or administered one day before the procedure. Post-procedure, NCDC says in a recent report, antibiotics should only be administered after a diagnosis of infection.

The report includes the results of a multi-centre survey led by the government agency which revealed most in-patients are given antibiotics for multiple days to prevent surgical site infection.

To determine the duration of surgical prophylaxis (the use of antibiotics for the prevention of surgical site infections) for patients, the administration of antibiotics within the previous 24 hours was observed and categorised as either one dose (S), multiple doses given in a single day (SP2), or multiple days (SP3).

The researchers found that most of the patients (91%) were put on SP3, only 1% patients were put on S and 8% patients were put on SP2.

Prolonged antibiotic administration to prevent infection is not only ineffective in reducing infections but increases antimicrobial resistance, according to the Indian Council of Medical Research (ICMR). In 2022, the ICMR issued an advisory stating most studies have suggested the efficacy of perioperative antibiotic prophylaxis for only 12 hours or less.

Related Posts

  • Pharma
  • July 26, 2024
  • 115 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 107 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD